[PDF] Top 20 Estilos de vida en pacientes hipertensos que acuden al centro de salud Tulcán Sur 2018
Has 10000 "Estilos de vida en pacientes hipertensos que acuden al centro de salud Tulcán Sur 2018" found on our website. Below are the top 20 most common "Estilos de vida en pacientes hipertensos que acuden al centro de salud Tulcán Sur 2018".
Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
... 10 anti- VEGF injections. These results suggest that anti-VEGF as used in clinical practice does not provide optimal outcomes in many patients, ie, a high proportion of patients ... See full document
20
Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)
... Visual and anatomic outcomes were suboptimal in a substantial number of patients in this study. After each of the first 16 injections, over 40% of patients did not achieve 20/40 or better BCVA and over 30% of ... See full document
61
Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study
... this study may have an impact on clinical practice patterns in DME management and could allow clarification of the optimal intervention in certain naïve, or poor, anti-VEGF ... See full document
21
Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis
... randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab in patients with center-involved DME, reported better visual and anatomical outcomes from baseline to 1 year with aflibercept, ... See full document
17
Intravitreal gas injection for the treatment of diabetic macular edema
... and edema in these refractory cases was ...on macular edema by a number of mechanisms: reduced VEGF production caus- ing decreased retinal vascular permeability; autoregulatory arteriolar ... See full document
6
Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema
... II study, the dexamethasone implant was well tolerated and had a favorable safety ...However, treatment-related cataract formation may take longer than 180 days to become ... See full document
15
Grading of macular perfusion in retinal vein occlusion using en-face swept-source optical coherence tomography angiography: a retrospective observational case series
... included macular edema and macular ischemia did not correlate with the vis- ual outcome of those ...ing macular edema and disrupted photoreceptors layer on ...present study has ... See full document
96
<p>Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8)</p>
... (EMR) study on nAMD patients treated with Ranibizumab, despite sharing a simi- lar baseline mean VA, their reported trend of VA change was less favourable ...this study, the reported mean VA gain was only 2 ... See full document
5
<p>The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer</p>
... received 1 or more IOP lowering drops to the lower IOP with none of them requiring incisional glaucoma surgery, demonstrating again that topical IOP lowering drops are effective and safe to use in those ... See full document
28
The clinical utility of aflibercept for diabetic macular edema
... CRT patterns suggest that 8 weeks approaches the average effective treatment interval for DME and AMD study ...of macular thicken- ing causes long-term compromise of macular morphology ... See full document
20
Comparison of different settings for yellow subthreshold laser treatment in diabetic macular edema
... Microperimetry (MAIA ™ , Centervue, Padova, Italy) Microperimetry was performed using the microperimeter (MAIA ™, Centervue, Padova, Italy) after dilation of pupils. Goldmann III stimuli and a 4–2-1 staircase ... See full document
90
Subthreshold diode-laser micropulse photocoagulation as a primary and secondary line of treatment in management of diabetic macular edema
... Baseline examination included Snellen best-corrected visual acuity, fundus photography, fluorescein angiography, and retinal thickness on OCT. OCT scans were obtained using the Stratus OCT-3 (Zeiss Humphrey Instruments, ... See full document
10
Critical appraisal of ranibizumab in the treatment of diabetic macular edema
... years 1 and 2, 47% of sham + laser, 57% of ranibi- zumab + deferred laser, 46% of triamcinolone + laser, and 72% of ranibizumab + deferred laser patients required no further laser ...years 1 and 2, the ... See full document
12
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
... Trial participants were 30 consecutive, consenting patients with newly diagnosed ischemic DME. Inclusion and exclusion criteria are listed in Table 2. BCVA was recorded as number of letters + 30 read on an ETDRS chart at ... See full document
7
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
... preferred treatment for DME (particularly DME with foveal involvement) on account of their established efficacy, low incidence of complications, and relative ease of ...or treatment-refractory DME, but ... See full document
7
Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation
... after treatment; the vision of some patients declined 6 months after treatment compared with 3 months after treatment, but there was still a significant difference in vision before treatment ... See full document
6
Incremental cost effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi
... As expected, the highest clinical outcomes are obtained with the age 30 scenario (0.804 QALYs gained, 0.466 DALYs averted and 7.068 years of severe visual impairment avoided per patients) due to longer time spent ... See full document
10
Nurse-administered intravitreal injections of anti-VEGF: study protocol for noninferiority randomized controlled trial of safety, cost and patient satisfaction
... IVI treatment in the injection room setting. A short and simple study-specific patient satisfaction question- naire was therefore developed in accordance with guidelines for measuring the quality of health ... See full document
9
Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy
... the study was calculated to be 0.695. Study groups were compared by one-way analysis of vari- ance ...the study subjects, were evaluated using receiver operator characteristic curve (ROC) analysis ... See full document
21
A Clinico-Pathological Study of the Structural and Functional Changes in the Retina and Optic Nerve Following Diabetic Retinopathy Treatments
... period, anti-VEGF treatments are often administered monthly until the patient becomes clinically stable and then receives injections on an as needed ...recent study has examined RNFL thickness in ... See full document
179
Related subjects